Toshiyuki Negoro
Sumitomo Dainippon Pharma (Japan)(JP)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Analytical Chemistry and Chromatography, Aldose Reductase and Taurine, Synthesis and Biological Evaluation, Synthesis and biological activity
Most-Cited Works
- → Novel, Highly Potent Aldose Reductase Inhibitors: (R)-(−)-2-(4-Bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine- 4-spiro-3‘-pyrrolidine-1,2‘,3,5‘-tetrone (AS-3201) and Its Congeners(1998)123 cited
- → Discovery of furan-2-carbohydrazides as orally active glucagon receptor antagonists(2014)66 cited
- → Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: A significant role of specific binding by serum albumin in the improved potency and stability(2005)41 cited
- → Synthesis and structure-activity relationships of 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives having narcotic agonist and antagonist activity(1987)34 cited
- → Studies on 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives and their analgesic activities. 2. Structure-activity relationships of 1-cycloalkyl-4-(1,2-diphenylethyl)piperazines(1978)21 cited
- → Determination of a new hypoglycemic drug, gliclazide, in human serum by radioimmunoassay.(1981)9 cited
- → Japanese collaborative study for fibrinogen assay: variability of the fibrinogen assay between different laboratories does not improve when a common calibrator is used(2005)7 cited
- → Effects of the Anti-Platelet Aggregation Drug Dilazep on Cognitive Function in Dahl Salt-Sensitive Rats.(2003)4 cited
- → Determination of ISF-2405, an active metabolite of cadralazine, in plasma and tissues by radioimmunoassay.(1987)2 cited
- → Determination of L-6-keto-piperidine-2-carbonyl-L-leucyl-L-proline amide (RGH-2202), a new analog of thyrotropin-releasing hormone, in plasma by radioimmunoassay.(1988)2 cited